Announcement • 2h
Guangdong Huate Gas Co., Ltd to Report First Half, 2026 Results on Aug 26, 2026 Guangdong Huate Gas Co., Ltd announced that they will report first half, 2026 results on Aug 26, 2026 New Risk • Apr 29
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.5% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risk Profit margins are more than 30% lower than last year (8.5% net profit margin). Announcement • Apr 10
Guangdong Huate Gas Co., Ltd, Annual General Meeting, May 14, 2026 Guangdong Huate Gas Co., Ltd, Annual General Meeting, May 14, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Foshan, Guangdong China Reported Earnings • Apr 10
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: CN¥1.13 (down from CN¥1.54 in FY 2024). Revenue: CN¥1.42b (up 1.7% from FY 2024). Net income: CN¥135.4m (down 27% from FY 2024). Profit margin: 9.5% (down from 13% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.2%. Earnings per share (EPS) also missed analyst estimates by 19%. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has remained flat. Announcement • Mar 30
Guangdong Huate Gas Co., Ltd to Report Q1, 2026 Results on Apr 29, 2026 Guangdong Huate Gas Co., Ltd announced that they will report Q1, 2026 results on Apr 29, 2026 New Risk • Mar 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (271% cash payout ratio). Share price has been volatile over the past 3 months (8.3% average weekly change). Valuation Update With 7 Day Price Move • Mar 13
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥78.80, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 25x in the Chemicals industry in China. Total loss to shareholders of 4.7% over the past three years. Reported Earnings • Mar 04
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: CN¥1.20 (down from CN¥1.54 in FY 2024). Revenue: CN¥1.42b (up 1.7% from FY 2024). Net income: CN¥143.8m (down 22% from FY 2024). Profit margin: 10% (down from 13% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.2%. Earnings per share (EPS) also missed analyst estimates by 19%. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 4% per year. Valuation Update With 7 Day Price Move • Jan 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥66.47, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 25x in the Chemicals industry in China. Total loss to shareholders of 11% over the past three years. Announcement • Dec 26
Guangdong Huate Gas Co., Ltd to Report Fiscal Year 2025 Results on Apr 10, 2026 Guangdong Huate Gas Co., Ltd announced that they will report fiscal year 2025 results on Apr 10, 2026 Price Target Changed • Dec 24
Price target increased by 11% to CN¥71.38 Up from CN¥64.32, the current price target is an average from 3 analysts. New target price is 18% above last closing price of CN¥60.67. Stock is up 27% over the past year. The company is forecast to post earnings per share of CN¥1.48 for next year compared to CN¥1.54 last year. Reported Earnings • Oct 31
Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2025 results: EPS: CN¥0.34 (up from CN¥0.31 in 3Q 2024). Revenue: CN¥367.6m (up 8.0% from 3Q 2024). Net income: CN¥41.1m (up 13% from 3Q 2024). Profit margin: 11% (in line with 3Q 2024). Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) missed analyst estimates by 39%. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. New Risk • Oct 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.6% average weekly change). Valuation Update With 7 Day Price Move • Oct 13
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥77.18, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 24x in the Chemicals industry in China. Total loss to shareholders of 14% over the past three years. Announcement • Sep 30
Guangdong Huate Gas Co., Ltd to Report Q3, 2025 Results on Oct 31, 2025 Guangdong Huate Gas Co., Ltd announced that they will report Q3, 2025 results on Oct 31, 2025 Valuation Update With 7 Day Price Move • Sep 25
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥67.65, the stock trades at a forward P/E ratio of 33x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years. Major Estimate Revision • Aug 29
Consensus revenue estimates fall by 15% The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥1.62b to CN¥1.38b. EPS estimate fell from CN¥1.82 to CN¥1.70 per share. Net income forecast to grow 21% next year vs 47% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥61.12. Share price fell 5.1% to CN¥57.47 over the past week. Announcement • Jun 30
Guangdong Huate Gas Co., Ltd to Report First Half, 2025 Results on Aug 28, 2025 Guangdong Huate Gas Co., Ltd announced that they will report first half, 2025 results on Aug 28, 2025 Declared Dividend • Jun 30
Dividend increased to CN¥0.60 Dividend of CN¥0.60 is 20% higher than last year. Ex-date: 3rd July 2025 Payment date: 3rd July 2025 Dividend yield will be 1.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but not covered by cash flows (dividend approximately 5x free cash flows). The dividend has increased by an average of 19% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 94% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Major Estimate Revision • Apr 19
Consensus EPS estimates fall by 11% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from CN¥2.14 to CN¥1.91 per share. Revenue forecast steady at CN¥1.62b. Net income forecast to grow 24% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥57.67 to CN¥61.15. Share price fell 3.4% to CN¥52.31 over the past week. Major Estimate Revision • Apr 16
Consensus revenue estimates fall by 11% The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥1.81b to CN¥1.61b. EPS estimate fell from CN¥2.31 to CN¥2.10 per share. Net income forecast to grow 23% next year vs 47% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥59.40. Share price rose 3.8% to CN¥54.86 over the past week. Reported Earnings • Apr 11
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: CN¥1.54 (up from CN¥1.43 in FY 2023). Revenue: CN¥1.40b (down 7.0% from FY 2023). Net income: CN¥184.8m (up 8.0% from FY 2023). Profit margin: 13% (up from 11% in FY 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 7.6%. Earnings per share (EPS) also missed analyst estimates by 3.8%. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Announcement • Apr 10
Guangdong Huate Gas Co., Ltd, Annual General Meeting, May 13, 2025 Guangdong Huate Gas Co., Ltd, Annual General Meeting, May 13, 2025, at 14:00 China Standard Time. Location: White Swan Hotel, Heshunfengxi Village, Lishui Town, Nanhai District, Foshan, Guangdong China Announcement • Mar 28
Guangdong Huate Gas Co., Ltd to Report Q1, 2025 Results on Apr 29, 2025 Guangdong Huate Gas Co., Ltd announced that they will report Q1, 2025 results on Apr 29, 2025 Major Estimate Revision • Mar 19
Consensus revenue estimates increase by 16% The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from CN¥1.99b to CN¥2.32b. EPS estimate reaffirmed at CN¥2.29. Net income forecast to grow 58% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target of CN¥58.67 unchanged from last update. Share price fell 2.3% to CN¥47.87 over the past week. Reported Earnings • Feb 26
Full year 2024 earnings released: EPS: CN¥1.52 (vs CN¥1.43 in FY 2023) Full year 2024 results: EPS: CN¥1.52 (up from CN¥1.43 in FY 2023). Revenue: CN¥1.40b (down 6.9% from FY 2023). Net income: CN¥181.2m (up 5.9% from FY 2023). Profit margin: 13% (up from 11% in FY 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 29% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Feb 06
Now 24% overvalued Over the last 90 days, the stock has fallen 21% to CN¥45.82. The fair value is estimated to be CN¥36.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 6.8%. Revenue is forecast to grow by 74% in 2 years. Earnings are forecast to grow by 104% in the next 2 years. Buy Or Sell Opportunity • Jan 14
Now 21% overvalued Over the last 90 days, the stock has fallen 14% to CN¥44.67. The fair value is estimated to be CN¥36.90, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 6.8%. Revenue is forecast to grow by 74% in 2 years. Earnings are forecast to grow by 104% in the next 2 years. Announcement • Dec 27
Guangdong Huate Gas Co., Ltd to Report Fiscal Year 2024 Results on Apr 10, 2025 Guangdong Huate Gas Co., Ltd announced that they will report fiscal year 2024 results on Apr 10, 2025 Reported Earnings • Oct 30
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: CN¥0.31 (down from CN¥0.39 in 3Q 2023). Revenue: CN¥340.5m (down 12% from 3Q 2023). Net income: CN¥36.5m (down 22% from 3Q 2023). Profit margin: 11% (down from 12% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 35%. Earnings per share (EPS) also missed analyst estimates by 44%. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥52.03, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 29% over the past three years. New Risk • Sep 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.5% average weekly change). Announcement • Sep 30
Guangdong Huate Gas Co., Ltd to Report Q3, 2024 Results on Oct 30, 2024 Guangdong Huate Gas Co., Ltd announced that they will report Q3, 2024 results on Oct 30, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥46.89, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 39% over the past three years. Announcement • Jun 29
Guangdong Huate Gas Co., Ltd to Report First Half, 2024 Results on Aug 30, 2024 Guangdong Huate Gas Co., Ltd announced that they will report first half, 2024 results on Aug 30, 2024 Reported Earnings • Apr 26
First quarter 2024 earnings: EPS and revenues miss analyst expectations First quarter 2024 results: EPS: CN¥0.38 (up from CN¥0.33 in 1Q 2023). Revenue: CN¥332.7m (down 7.3% from 1Q 2023). Net income: CN¥45.1m (up 13% from 1Q 2023). Profit margin: 14% (up from 11% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 22%. Earnings per share (EPS) also missed analyst estimates by 8.4%. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 14
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥1.43 (down from CN¥1.72 in FY 2022). Revenue: CN¥1.50b (down 17% from FY 2022). Net income: CN¥171.1m (down 17% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 9.8%. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Announcement • Apr 12
Guangdong Huate Gas Co., Ltd, Annual General Meeting, May 08, 2024 Guangdong Huate Gas Co., Ltd, Annual General Meeting, May 08, 2024, at 14:00 China Standard Time. Location: No. 32, Heshun Yanjiang North Road, Lishui Town, Nanhai District, Foshan, Guangdong China Announcement • Mar 29
Guangdong Huate Gas Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024 Guangdong Huate Gas Co., Ltd announced that they will report Q1, 2024 results on Apr 26, 2024 Price Target Changed • Mar 07
Price target decreased by 7.3% to CN¥69.81 Down from CN¥75.31, the current price target is an average from 4 analysts. New target price is 42% above last closing price of CN¥49.24. Stock is down 39% over the past year. The company is forecast to post earnings per share of CN¥1.99 for next year compared to CN¥1.37 last year. Major Estimate Revision • Mar 01
Consensus revenue estimates fall by 10% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥2.12b to CN¥1.90b. EPS estimate fell from CN¥2.28 to CN¥2.21 per share. Net income forecast to grow 62% next year vs 59% growth forecast for Chemicals industry in China. Consensus price target down from CN¥80.56 to CN¥75.31. Share price rose 4.1% to CN¥50.85 over the past week. Reported Earnings • Feb 24
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥1.37 (down from CN¥1.72 in FY 2022). Revenue: CN¥1.50b (down 17% from FY 2022). Net income: CN¥164.7m (down 20% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 14%. Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Feb 06
Now 23% overvalued Over the last 90 days, the stock has fallen 40% to CN¥43.00. The fair value is estimated to be CN¥34.84, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 20%. Revenue is forecast to grow by 64% in 2 years. Earnings are forecast to grow by 143% in the next 2 years. New Risk • Jan 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.6% average weekly change). Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥55.49, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 7.6% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥35.59 per share. Valuation Update With 7 Day Price Move • Jan 08
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥56.73, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 15x in the Chemicals industry in China. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥35.80 per share. Major Estimate Revision • Nov 02
Consensus EPS estimates fall by 18% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥1.89b to CN¥1.74b. EPS estimate also fell from CN¥1.89 per share to CN¥1.55 per share. Net income forecast to grow 81% next year vs 66% growth forecast for Chemicals industry in China. Consensus price target down from CN¥87.63 to CN¥78.43. Share price rose 8.5% to CN¥68.35 over the past week. Price Target Changed • Oct 29
Price target decreased by 10% to CN¥78.43 Down from CN¥87.63, the current price target is an average from 4 analysts. New target price is 19% above last closing price of CN¥65.95. Stock is down 25% over the past year. The company is forecast to post earnings per share of CN¥1.55 for next year compared to CN¥1.72 last year. Reported Earnings • Oct 27
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: EPS: CN¥0.39 (down from CN¥0.56 in 3Q 2022). Revenue: CN¥388.6m (down 25% from 3Q 2022). Net income: CN¥47.0m (down 31% from 3Q 2022). Profit margin: 12% (down from 13% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 27%. Earnings per share (EPS) also missed analyst estimates by 36%. Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 16
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥58.06, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 29% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥110 per share. Price Target Changed • Aug 13
Price target decreased by 15% to CN¥89.50 Down from CN¥105, the current price target is an average from 3 analysts. New target price is 42% above last closing price of CN¥63.20. Stock is down 31% over the past year. The company is forecast to post earnings per share of CN¥2.04 for next year compared to CN¥1.72 last year. Reported Earnings • Aug 10
Second quarter 2023 earnings released: EPS: CN¥0.29 (vs CN¥0.66 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.29 (down from CN¥0.66 in 2Q 2022). Revenue: CN¥381.7m (down 24% from 2Q 2022). Net income: CN¥34.6m (down 56% from 2Q 2022). Profit margin: 9.1% (down from 16% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • May 19
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥85.84, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 4.1% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥79.92 per share. Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.33 (vs CN¥0.33 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.33 (in line with 1Q 2022). Revenue: CN¥358.9m (down 6.4% from 1Q 2022). Net income: CN¥40.0m (up 2.2% from 1Q 2022). Profit margin: 11% (up from 10% in 1Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 26
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥78.34, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 48% over the past three years. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥99.19, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 88% over the past three years. Price Target Changed • Nov 16
Price target increased to CN¥111 Up from CN¥97.76, the current price target is provided by 1 analyst. New target price is 27% above last closing price of CN¥87.27. Stock is up 5.1% over the past year. The company is forecast to post earnings per share of CN¥1.70 for next year compared to CN¥1.08 last year. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Jin Lu was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 18
Third quarter 2022 earnings released: EPS: CN¥0.56 (vs CN¥0.31 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.56 (up from CN¥0.31 in 3Q 2021). Revenue: CN¥519.2m (up 49% from 3Q 2021). Net income: CN¥67.9m (up 83% from 3Q 2021). Profit margin: 13% (up from 11% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Oct 13
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥95.17, the stock trades at a forward P/E ratio of 50x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 26% over the past year. Valuation Update With 7 Day Price Move • Sep 05
Investor sentiment improved over the past week After last week's 35% share price gain to CN¥110, the stock trades at a forward P/E ratio of 58x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 37% over the past year. Reported Earnings • Aug 31
Second quarter 2022 earnings released: EPS: CN¥0.66 (vs CN¥0.32 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.66 (up from CN¥0.32 in 2Q 2021). Revenue: CN¥500.3m (up 41% from 2Q 2021). Net income: CN¥79.0m (up 107% from 2Q 2021). Profit margin: 16% (up from 11% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 31%, compared to a 40% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Aug 01
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥77.70, the stock trades at a forward P/E ratio of 50x. Average forward P/E is 17x in the Chemicals industry in China. Total loss to shareholders of 18% over the past year. Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥74.82, the stock trades at a forward P/E ratio of 48x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 9.1% over the past year. Announcement • May 12
Guangdong Huate Gas Co., Ltd (SHSE:688268) announces an Equity Buyback for CNY 80 million worth of its shares. Guangdong Huate Gas Co., Ltd (SHSE:688268) announces a share repurchase program. Under the program, the company will repurchase up to CNY 80 million worth of shares. The shares will be repurchased at a price of not more than CNY 85 per share. The shares purchased will be used for the company's equity incentive plan or ESOP. The program will be valid for 12 months. Reported Earnings • May 02
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2022 results: EPS: CN¥0.33 (up from CN¥0.23 in 1Q 2021). Revenue: CN¥383.5m (up 31% from 1Q 2021). Net income: CN¥39.2m (up 41% from 1Q 2021). Profit margin: 10% (in line with 1Q 2021). Revenue exceeded analyst estimates by 9.4%. Earnings per share (EPS) missed analyst estimates by 13%. Over the next year, revenue is forecast to grow 24%, compared to a 42% growth forecast for the industry in China. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Jin Lu was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Apr 02
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: CN¥1.07 (up from CN¥0.89 in FY 2020). Revenue: CN¥1.35b (up 35% from FY 2020). Net income: CN¥128.0m (up 20% from FY 2020). Profit margin: 9.5% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 9.4%. Earnings per share (EPS) missed analyst estimates by 13%. Over the next year, revenue is forecast to grow 17%, compared to a 47% growth forecast for the industry in China. Reported Earnings • Feb 28
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: CN¥1.07 (up from CN¥0.89 in FY 2020). Revenue: CN¥1.35b (up 35% from FY 2020). Net income: CN¥128.0m (up 20% from FY 2020). Profit margin: 9.5% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 9.4%. Earnings per share (EPS) missed analyst estimates by 14%. Over the next year, revenue is forecast to grow 17%, compared to a 47% growth forecast for the industry in China. Valuation Update With 7 Day Price Move • Dec 15
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥88.17, the stock trades at a forward P/E ratio of 55x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 49% over the past year. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.31 (vs CN¥0.26 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥347.5m (up 33% from 3Q 2020). Net income: CN¥37.2m (up 19% from 3Q 2020). Profit margin: 11% (down from 12% in 3Q 2020). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Sep 01
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥79.50, the stock trades at a forward P/E ratio of 57x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 9.7% over the past year. Reported Earnings • Aug 20
Second quarter 2021 earnings released: EPS CN¥0.32 (vs CN¥0.22 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥354.0m (up 52% from 2Q 2020). Net income: CN¥38.1m (up 45% from 2Q 2020). Profit margin: 11% (in line with 2Q 2020). Valuation Update With 7 Day Price Move • Jun 19
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥75.15, the stock trades at a forward P/E ratio of 58x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 6.1% over the past year. Valuation Update With 7 Day Price Move • Jun 01
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥69.28, the stock trades at a forward P/E ratio of 53x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 28% over the past year. Reported Earnings • Apr 30
First quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.14 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥293.4m (up 55% from 1Q 2020). Net income: CN¥27.8m (up 68% from 1Q 2020). Profit margin: 9.5% (in line with 1Q 2020). Is New 90 Day High Low • Dec 16
New 90-day low: CN¥59.12 The company is down 22% from its price of CN¥75.75 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.42 per share. Is New 90 Day High Low • Oct 26
New 90-day low: CN¥64.56 The company is down 22% from its price of CN¥82.59 on 28 July 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.44 per share. Is New 90 Day High Low • Sep 28
New 90-day low: CN¥67.50 The company is down 27% from its price of CN¥92.55 on 30 June 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.42 per share. Announcement • Jul 17
Guangdong Huate Gas Co., Ltd to Report First Half, 2020 Results on Aug 28, 2020 Guangdong Huate Gas Co., Ltd announced that they will report first half, 2020 results on Aug 28, 2020 